Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer

Background: Mucosa-associated lymphoma antigen 1 (MALT1) is an oncogene in subsets of diffuse large B cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue type (MALT) lymphoma. However, the role of MALT1 across cancers, especially in prostate cancer is still poorly understood.Methods: Here, w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Haotian Tan, Yaqi Xie, Xuebao Zhang, Shuang Wu, Hongwei Zhao, Jitao Wu, Wenting Wang, Chunhua Lin
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/7514fc33039a417bbfbb282ec6bf844e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7514fc33039a417bbfbb282ec6bf844e
record_format dspace
spelling oai:doaj.org-article:7514fc33039a417bbfbb282ec6bf844e2021-12-02T09:23:49ZIntegrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer2296-889X10.3389/fmolb.2021.714906https://doaj.org/article/7514fc33039a417bbfbb282ec6bf844e2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmolb.2021.714906/fullhttps://doaj.org/toc/2296-889XBackground: Mucosa-associated lymphoma antigen 1 (MALT1) is an oncogene in subsets of diffuse large B cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue type (MALT) lymphoma. However, the role of MALT1 across cancers, especially in prostate cancer is still poorly understood.Methods: Here, we used several public datasets to evaluate MALT1 expression. Then, PCa cell lines and nude mice were used to investigate the cellular functions in vitro and in vivo. Microarray data were downloaded from The Cancer Genome Atlas and MALT1 was subjected to gene set enrichment analysis (GSEA) and Gene Ontology (GO) analysis to identify the biological functions and relevant pathways. Additionally, the correlations between MALT1 expression and mismatch repair (MMR) gene mutation, immune checkpoint gene expression, tumor mutational burden (TMB), and microsatellite instability (MSI) were investigated by Pearson correlation analysis. Moreover, the correlation between MALT1 expression and tumor immune infiltration was analyzed by the Tumor Immune Evaluation Resource (TIMER) database.Results: MALT1 overexpression was significantly correlated with MMR gene mutation levels and crucially promoted proliferation and colony genesis while reducing PCa cell apoptosis levels in vivo and in vitro. MALT1 expression showed strong correlations with immune checkpoint genes, TMB, and MSI in most cancers. The GO analysis indicated that MALT1-coexpressed genes were involved in heterotypic cell-cell adhesion, actin filament-based movement regulation, and action potential regulation. GSEA revealed that MALT1 expression was associated with several signaling pathways, including the NF-κB signaling, Wnt/β-catenin and TGF-β signaling pathways, in PCa. Additionally, MALT1 expression was significantly correlated with the infiltration of immune cells, including B cells, CD8+ T cells, dendritic cells and macrophages, and negatively correlated with CD4+ cell infiltration in PCa.Conclusion: MALT1 expression is higher in pancancer samples than in normal tissues. MALT1 promoted proliferation and colony genesis while reducing PCa cell apoptosis levels, and MALT1 suppression could inhibit xenograft tumor establishment in nude mice. Furthermore, MALT1 expression is closely related to the occurrence and development of multiple tumors in multiple ways. Therefore, MALT1 may be an emerging therapeutic target for a variety of cancers especially PCa.Haotian TanYaqi XieXuebao ZhangShuang WuHongwei ZhaoJitao WuWenting WangChunhua LinFrontiers Media S.A.articleprostate cancerpancancerMalt1bioinformatics analysistherapeutic targetBiology (General)QH301-705.5ENFrontiers in Molecular Biosciences, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic prostate cancer
pancancer
Malt1
bioinformatics analysis
therapeutic target
Biology (General)
QH301-705.5
spellingShingle prostate cancer
pancancer
Malt1
bioinformatics analysis
therapeutic target
Biology (General)
QH301-705.5
Haotian Tan
Yaqi Xie
Xuebao Zhang
Shuang Wu
Hongwei Zhao
Jitao Wu
Wenting Wang
Chunhua Lin
Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
description Background: Mucosa-associated lymphoma antigen 1 (MALT1) is an oncogene in subsets of diffuse large B cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue type (MALT) lymphoma. However, the role of MALT1 across cancers, especially in prostate cancer is still poorly understood.Methods: Here, we used several public datasets to evaluate MALT1 expression. Then, PCa cell lines and nude mice were used to investigate the cellular functions in vitro and in vivo. Microarray data were downloaded from The Cancer Genome Atlas and MALT1 was subjected to gene set enrichment analysis (GSEA) and Gene Ontology (GO) analysis to identify the biological functions and relevant pathways. Additionally, the correlations between MALT1 expression and mismatch repair (MMR) gene mutation, immune checkpoint gene expression, tumor mutational burden (TMB), and microsatellite instability (MSI) were investigated by Pearson correlation analysis. Moreover, the correlation between MALT1 expression and tumor immune infiltration was analyzed by the Tumor Immune Evaluation Resource (TIMER) database.Results: MALT1 overexpression was significantly correlated with MMR gene mutation levels and crucially promoted proliferation and colony genesis while reducing PCa cell apoptosis levels in vivo and in vitro. MALT1 expression showed strong correlations with immune checkpoint genes, TMB, and MSI in most cancers. The GO analysis indicated that MALT1-coexpressed genes were involved in heterotypic cell-cell adhesion, actin filament-based movement regulation, and action potential regulation. GSEA revealed that MALT1 expression was associated with several signaling pathways, including the NF-κB signaling, Wnt/β-catenin and TGF-β signaling pathways, in PCa. Additionally, MALT1 expression was significantly correlated with the infiltration of immune cells, including B cells, CD8+ T cells, dendritic cells and macrophages, and negatively correlated with CD4+ cell infiltration in PCa.Conclusion: MALT1 expression is higher in pancancer samples than in normal tissues. MALT1 promoted proliferation and colony genesis while reducing PCa cell apoptosis levels, and MALT1 suppression could inhibit xenograft tumor establishment in nude mice. Furthermore, MALT1 expression is closely related to the occurrence and development of multiple tumors in multiple ways. Therefore, MALT1 may be an emerging therapeutic target for a variety of cancers especially PCa.
format article
author Haotian Tan
Yaqi Xie
Xuebao Zhang
Shuang Wu
Hongwei Zhao
Jitao Wu
Wenting Wang
Chunhua Lin
author_facet Haotian Tan
Yaqi Xie
Xuebao Zhang
Shuang Wu
Hongwei Zhao
Jitao Wu
Wenting Wang
Chunhua Lin
author_sort Haotian Tan
title Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
title_short Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
title_full Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
title_fullStr Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
title_full_unstemmed Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
title_sort integrative analysis of malt1 as a potential therapeutic target for prostate cancer and its immunological role in pan-cancer
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/7514fc33039a417bbfbb282ec6bf844e
work_keys_str_mv AT haotiantan integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT yaqixie integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT xuebaozhang integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT shuangwu integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT hongweizhao integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT jitaowu integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT wentingwang integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
AT chunhualin integrativeanalysisofmalt1asapotentialtherapeutictargetforprostatecanceranditsimmunologicalroleinpancancer
_version_ 1718398128494739456